Showing results (421-430 of 654) with videos related to
Sort By:
Pageof 66
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.Nature Medicine|July 16, 2020
A stochastic agent-based model of the SARS-CoV-2 epidemic in FranceNicolas Hoertel, Martin Blachier, Carlos Blanco, et al.The Journal of Clinical Psychiatry|April 10, 2020
Contributing Factors to Heterogeneity in the Timing of the Onset of Nonfatal Suicidal Behavior: Results From a Nationally Representative StudyNicolas Hoertel, Julien Sabatier, Carlos Blanco, et al.Archives of Internal Medicine|February 5, 2002
Borderline personality disorder in primary careRaz Gross, Mark Olfson, Marc Gameroff, et al.Pharmacoepidemiology and Drug Safety|March 26, 2014
Validation of a claims-based antipsychotic polypharmacy measureEmily Leckman-Westin, Edith Kealey, Nitin Gupta, et al.The American Journal of Psychiatry|August 3, 2002
Psychotic symptoms in an urban general medicine practiceMark Olfson, Roberto Lewis-Fernández, Myrna M Weissman, et al.Journal of the American Academy of Child and Adolescent Psychiatry|January 24, 2012
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorderMark Olfson, Cecilia Huang, Tobias Gerhard, et al.JAMA Psychiatry|March 10, 2021
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With SchizophreniaT Scott Stroup, Mark Olfson, Cecilia Huang, et al.Psychiatric Services (Washington, D.C.)|August 23, 2012
Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity SurveyMathilde M Husky, Mark Olfson, Jian-ping He, et al.Current Psychiatry Reports|July 25, 2013
Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implicationsMichael L Birnbaum, Ema Saito, Tobias Gerhard, et al.Pageof 66